億勝生物科技有限公司（01061）于2026年3月3日公告了截至2026年2月28日的股份变动月报表。公告显示，公司法定股本数量为1,000,000,000股，面值0.1港元，法定股本总额维持在1亿港元，报告期内无任何增加或减少。
公司已发行股份（不含库存股）在2月底维持于567,006,000股，与上月底持平，期间无新增发行、回购、注销或库存股变动。公告确认，截至报告期末，公司目前所持公众流通股比例符合香港联交所相关规定。
就股权激励方面，2023年6月9日股东大会通过的购股权计划在期内无新增行使或失效，仍可对应发行或转让股份总数为57,064,900股。截至2月底，公司整体股本结构保持稳定。
本次月报经董事方海洲签署并呈交香港联合交易所有限公司。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.